Aim Grow Biotech

Aim-Grow Biotech is a biopharmaceutical company based in Suzhou, China, specializing in the field of targeted protein degradation (TPD). The company utilizes its proprietary Aim-Deg platform to design and develop next-generation small molecule therapeutics, including PROTACs and molecular glues. These modalities are designed to eliminate disease-causing proteins that are often considered "undruggable" by traditional occupancy-based inhibitors. Aim-Grow's primary therapeutic focus lies in oncology and immunology, where they aim to provide transformative treatments for patients with limited options. The company is backed by leading venture capital firms and operates within the BioBAY biotechnology cluster.